Supaverm Oral Suspension

Χώρα: Ηνωμένο Βασίλειο

Γλώσσα: Αγγλικά

Πηγή: VMD (Veterinary Medicines Directorate)

Δραστική ουσία:

Closantel, Mebendazole

Διαθέσιμο από:

Elanco Europe Ltd

Φαρμακολογική κατηγορία (ATC):

QP52A

INN (Διεθνής Όνομα):

Closantel, Mebendazole

Φαρμακοτεχνική μορφή:

Oral suspension

Τρόπος διάθεσης:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Θεραπευτική ομάδα:

Sheep

Θεραπευτική περιοχή:

Anthelmintic flukicide

Καθεστώς αδειοδότησης:

Authorized

Ημερομηνία της άδειας:

1988-04-11

Αρχείο Π.Χ.Π.

Revised: March 2023
AN: 02210/2022
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Supaverm Oral Suspension
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
% w/v
Closantel (as closantel sodium dihydrate)
5
Mebendazole
7.5
EXCIPIENTS:
For full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Oral Suspension
White to faintly cream coloured suspension
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Sheep and lambs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the control of fascioliasis (due to _Fasciola hepatica_) and
gastrointestinal nematodes
and cestodes in sheep and lambs. The combination is active against
lungworm,
roundworms, tapeworms (heads and segments) and fluke (mature and
immature).
For the control of the larval stages of_ Oestrus ovis _(Sheep Nasal
Bot fly).
For the control of inhibited, immature and adult stages of _Haemonchus
contortus_ (Barber
Pole worm) including benzimidazole resistant strains.
Also effective against benzimidazole susceptible strains of the
following:
GASTRO-INTESTINAL ROUNDWORMS: _Ostertagia_ spp, _Trichostrongylus_
spp, _Nematodirus_ spp,
_Cooperia_ spp, _Oesophagostomum_ spp, _Chabertia ovina, Bunostomum_
spp, _Trichurus _
_ovis_, _Strongyloides papillosus_.
LUNGWORM: _Dictyocaulus_ _filaria_
TAPEWORM: _Moniezia_ spp.
Revised: March 2023
AN: 02210/2022
Page 2 of 7
_Fluke activity:_
_Stage_
_Percentage kill_
Adults
97-100 %
6-8 weeks immature
91-95 %
5 weeks immature
91 %
3-4 weeks immature
23-73 %
Ticks (_Ixodes ricinus_) feeding on sheep at the time of treatment are
likely to produce fewer
viable eggs.
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR TARGET SPECIES
Care should be taken to avoid the following practices because they
increase the risk of
development of resistance and could ultimately result in ineffective
therapy:
•
Too frequent and repeated use of anthelmintics from the same class,
over an
extended period of time.
•
Underdosing, which may be due to underestimation of body weight